Sage Journals: Discover world-class research

Abstract

Background

Invasive cribriform carcinoma (ICC) of the breast is a rare type of invasive carcinoma which shows a favorable prognosis and a lower frequency of axillary nodal metastases. Few imaging findings related to ICC have been reported.

Purpose

To evaluate imaging findings with multiple imaging techniques in ICC of the breast.

Material and Methods

Twenty-eight cases of histopathologically proven ICC of the breast were gathered for this study. We retrospectively reviewed the mammographic, sonographic, and magnetic resonance imaging (MRI) findings of ICC according to the American College of Radiology (ACR) breast imaging reporting and data system (BI-RADS) lexicon. 18 F-fluorodeoxyglucose positron emission tomography-computed tomography (18 F-FDG PET-CT) findings were also evaluated. Microscopic slides of surgical specimens were reviewed by a breast pathologist.

Results

The mean age of the patients was 51 years. The most common mammographic findings were irregular shape (72.8%), spiculated margin (63.7%), and a high density (81.8%) mass. Microcalcifications were noted in 9/28 cases. The most common shape was pleomorphic (66.7%). The most common sonographic findings were irregular shape (77.8%), spiculated margin (29.6%), hypoechogenicity (81.5%), and no posterior acoustic features (85.2%). On MRI, most ICCs presented as irregular shaped mass (62.0%) and irregular (42.9%) margin. All four patients (16.0%) who presented with non-mass-like enhancement pattern showed a segmental distribution. The 18 F-FDG PET-CT showed a mean maximum standardized uptake value (SUVmax) of 5.90. Axillary nodal metastases were found in 17.9% (5/28) of the surgical specimens. Immunohistochemical studies showed a high positivity for estrogen and progesterone receptor (100% and 87.5%, respectively).

Conclusion

The imaging features of invasive cribriform carcinoma are highly suggestive of malignancy and are not distinguishable from those of other breast cancers like infiltrating ductal carcinoma.

Keywords

Breast neoplasms – primary mammography ultrasound magnetic resonance imaging (MRI)positron emission tomography (PET)

Get full access to this article

View all access options for this article.

References

Page

Dixon

Anderson

. Invasive cribriform carcinoma of the breast. Histopathology 1983; 7: 525–536.

Cribriform carcinoma. In: Rosen PP, ed. Rosen’s breast pathology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:551–553.

Venable

Schwartz

Silverberg

. Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity. Hum Pathol 1990; 21: 333–338.

Marzullo

Zito

Marzullo

. Infiltrating cribriform carcinoma of the breast. A clinicopathologic and immunohistochemical study of 5 cases. Eur J Gynaecol Oncol 1996; 17: 228–231.

Stutz

Evans

Pinder

. The radiological appearances of invasive cribriform carcinoma of the breast. Clin Radiol 1994; 49: 693–695.

Nishimura

Ohsumi

Teramoto

. Invasive cribriform carcinoma with extensive microcalcifications in the male breast. Breast Cancer 2005; 12: 145–148.

Lim

Jeong

Lee

. Sonographic findings of invasive cribriform carcinoma of the breast. J Ultrasound Med 2011; 30: 701–705.

Heo

Lim

Lee

. Invasive Cribriform Carcinoma of the Breast: A Case Report. J Korean Soc Radiol 2011; 64: 83–86.

Yang

Chang

Metreweli

. Patients with breast cancer: differences in color Doppler flow and gray-scale US features of benign and malignant axillary lymph nodes. Radiology 2000; 215: 568–573.

10.

Elston

Ellis

. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403–410.

11.

Cole-Beuglet

Soriano

Kurtz

. Ultrasound analysis of 104 primary breast carcinomas classified according to histopathologic type. Radiology 1983; 147: 191–196.

12.

Thomas

Thickman

Rapp

. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 1995; 196: 123–134.

13.

Blaichman

Marcus

Alsaadi

. Sonographic appearance of invasive ductal carcinoma of the breast according to histologic grade. Am J Roentgenol 2012; 199: W402–W408.

14.

Lamb

Perry

Vinnicombe

. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast. Clin Radiol 2000; 55: 40–44.

15.

Rotstein

Neerhut

. Ultrasound characteristics of histologically proven grade 3 invasive ductal breast carcinoma. Australas Radiol 2005; 49: 476–479.

16.

Schrading

Kuhl

. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology 2008; 246: 58–70.

17.

Liberman

Morris

Lee

. Breast lesions detected on MR imaging: features and positive predictive value. Am J Roentgenol 2002; 179: 171–178.

18.

Tozaki

Fukuda

. High-spatial-resolution MRI of non-masslike breast lesions: interpretation model based on BI-RADS MRI descriptors. Am J Roentgenol 2006; 18: 330–337.

19.

Orel

Mendonca

Reynolds

. MR imaging of ductal carcinoma in situ. Radiology 1997; 202: 413–420.

20.

Ueda

Tsuda

Asakawa

. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol 2008; 38: 250–258.

21.

Kim

Sung

. Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer. Ann Nucl Med 2012; 26: 175–183.

22.

Buck

Schirrmeister

Kühn

. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging 2002; 29: 1317–1323.

23.

Song

Hong

Lee

. Prognostic value of primary tumor uptake on F-18 FDG PET/CT in patients with invasive ductal breast cancer. Nucl Med Mol Imaging 2011; 45: 117–124.

24.

Inoue

Yutani

Taguchi

. Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-Deoxy-2-fluoro-D-glucose-positron emission tomography. J Cancer Res Clin Oncol 2004; 130: 273–278.

25.

Seo

Bae

Han

. Clinicopathological characteristics in invasive ductal breast cancer with low FDG uptake in 18F-FDG PET/CT. J Breast Cancer 2010; 13: 83–89.

26.

Avril

Menzel

Dose

. Glucose metabolism of breast cancer assessed by 18F-FDG PET; histologic and immunohistochemical tissue analysis. J Nucl Med 2001; 42: 9–16.

27.

Gil-Rendo

Martinez-Regueria

Zornoza

. Association between [18F] fluorodeoxyglucose uptake and prognostic parameters in breast cancer. Br J Surg 2009; 96: 166–170.

28.

Cermik

Mavi

Basu

. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging 2008; 35: 475–483.

29.

Avril

Rose

Schelling

. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 2000; 18: 3495–3502.

30.

Kumar

Chauhan

Zhuang

. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat 2006; 98: 267–274.

31.

Zhang

Lin

. Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified. Int J Clin Exp Pathol 2013; 6: 445–457.